Institutional
Defilade Capital Management, L.P.
CIK 0002088557
$712.2M
Reported AUM
31
Positions
Q1 2026
Period
2026-05-14
Filed
The Brief · Defilade Capital Management, L.P. · Q1 2026
AI · grounded in 13F
Defilade Capital Management, L.P. closed its position in ABBV for a reduction of $52.02M. The fund established new positions in ZBH for $52.37M and PTCT for $41.11M. Other notable activity includes closing its stake in NVS for $50.02M and increasing its share count in INSM by 289.8%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZBH | ZIMMER BIOMET HOLDINGS INC | $87.33 | 0.74% | -4.48% | -42.68% | $52.4M | 7.35% | +579,161 | NEW |
| 2 | HSIC | SCHEIN HENRY INC | $77.45 | 1.51% | 10.06% | -3.37% | $46.0M | 6.46% | +303,615 | +94.8% |
| 3 | BDX | BECTON DICKINSON & CO | $151.16 | 1.07% | 13.46% | -16.52% | $43.9M | 6.16% | +198,003 | +243.8% |
| 4 | PTCT | PTC THERAPEUTICS INC | $70.97 | 0.47% | 36.14% | 85.16% | $41.1M | 5.77% | +376,165 | NEW |
| 5 | DXCM | DEXCOM INC | $72.86 | 0.37% | -15.93% | -43.47% | $33.8M | 4.75% | +293,881 | +120.0% |
| 6 | ICUI | ICU MED INC | $136.61 | 1.25% | 2.66% | -32.80% | $32.8M | 4.61% | −86,454 | −25.4% |
| 7 | INSM | INSMED INC | $94.22 | -10.20% | 27.98% | 283.01% | $31.9M | 4.48% | +144,909 | +289.8% |
| 8 | ISRG | INTUITIVE SURGICAL INC | $422.06 | 0.77% | -24.24% | 27.71% | $31.2M | 4.38% | +22,019 | +48.2% |
| 9 | RVMD | REVOLUTION MEDICINES INC | $149.23 | -4.15% | 263.18% | 421.05% | $30.7M | 4.31% | −47,482 | −13.1% |
| 10 | GMED | GLOBUS MED INC | $80.00 | 0.00% | 33.51% | -3.81% | $30.5M | 4.29% | +87,138 | +32.6% |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | $163.88 | -2.07% | 30.70% | 75.82% | $27.7M | 3.88% | +209,932 | NEW |
| 12 | DNLI | DENALI THERAPEUTICS INC | $19.52 | -3.08% | 32.79% | -61.75% | $26.1M | 3.67% | +703,256 | +107.1% |
| 13 | PACS | PACS GROUP INC | $37.01 | -1.23% | 254.50% | 21.74% | $25.6M | 3.60% | −541,305 | −47.3% |
| 14 | OLMA | OLEMA PHARMACEUTICALS INC | $10.31 | -3.46% | 131.17% | -56.09% | $22.4M | 3.15% | +269,902 | +21.9% |
| 15 | ELAN | ELANCO ANIMAL HEALTH INC | $23.63 | -4.37% | 70.00% | -35.21% | $22.3M | 3.13% | +529,838 | +132.0% |
| 16 | PFE | PFIZER INC | $26.04 | 1.36% | 19.31% | -21.41% | $19.4M | 2.72% | −739,375 | −33.6% |
| 17 | LLY | ELI LILLY & CO | $1131.42 | 0.55% | 48.00% | 387.10% | $19.0M | 2.67% | −11,254 | −35.2% |
| 18 | LNTH | LANTHEUS HLDGS INC | $100.98 | -1.79% | 23.83% | 285.86% | $18.9M | 2.66% | +249,401 | NEW |
| 19 | ITGR | INTEGER HLDGS CORP | $91.98 | -0.82% | -24.19% | -6.04% | $18.7M | 2.63% | +213,027 | NEW |
| 20 | BIIB | BIOGEN INC | $195.34 | -0.57% | 46.73% | -40.21% | $17.7M | 2.48% | −65,703 | −40.6% |
| 21 | EVMN | EVOMMUNE INC | $19.92 | -3.72% | 8.20% | 16.36% | $15.6M | 2.19% | +463,171 | +215.0% |
| 22 | TNDM | TANDEM DIABETES CARE INC | $19.34 | -0.57% | -6.93% | -82.20% | $14.6M | 2.05% | +761,905 | NEW |
| 23 | COGT | COGENT BIOSCIENCES INC | $31.02 | -5.40% | 356.18% | 417.00% | $13.6M | 1.91% | −216,029 | −38.0% |
| 24 | NUVL | NUVALENT INC | $90.95 | -3.27% | 16.57% | 149.66% | $13.3M | 1.87% | −139,093 | −51.7% |
| 25 | OCUL | OCULAR THERAPEUTIX INC | $8.25 | -6.25% | -8.54% | -25.07% | $12.6M | 1.77% | +805,982 | +118.2% |
| 26 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $11.9M | 1.67% | −33,799 | −39.4% |
| 27 | ALGN | ALIGN TECHNOLOGY INC | $167.74 | -0.33% | -7.13% | -75.89% | $11.5M | 1.62% | −60,728 | −47.4% |
| 28 | ELDN | ELEDON PHARMACEUTICALS INC | $3.41 | -5.28% | 10.71% | -47.46% | $11.0M | 1.54% | +273,677 | +8.3% |
| 29 | ORIC | ORIC PHARMACEUTICALS INC | $7.50 | -6.48% | -19.53% | -54.95% | $10.7M | 1.50% | +842,928 | NEW |
| 30 | BHVN | BIOHAVEN LTD | $10.80 | -5.26% | -36.58% | -34.82% | $2.7M | 0.38% | +315,944 | NEW |
| 31 | MREO | MEREO BIOPHARMA GROUP PLC | $0.31 | -1.57% | — | — | $2.5M | 0.35% | +7,558,756 | NEW |
| 32 | ABBV | ABBVIE INC | $227.23 | 1.02% | — | — | — | — | −227,669 | EXITED |
| 33 | NVS | NOVARTIS AG | $149.16 | 0.51% | — | — | — | — | −362,816 | EXITED |
| 34 | STE | STERIS PLC | $212.35 | 0.05% | — | — | — | — | −135,307 | EXITED |
| 35 | XNCR | XENCOR INC | $11.77 | -2.00% | — | — | — | — | −1,414,755 | EXITED |
| 36 | ATRC | ATRICURE INC | $27.10 | -0.62% | — | — | — | — | −397,636 | EXITED |
| 37 | LIVN | LIVANOVA PLC | $72.36 | -1.84% | — | — | — | — | −241,413 | EXITED |
| 38 | ATEC | ALPHATEC HLDGS INC | $8.00 | 1.01% | — | — | — | — | −626,754 | EXITED |
| 39 | GKOS | GLAUKOS CORP | $125.00 | 2.72% | — | — | — | — | −91,703 | EXITED |
| 40 | RXST | RXSIGHT INC | $5.00 | -1.96% | — | — | — | — | −913,090 | EXITED |
| 41 | TFX | TELEFLEX INCORPORATED | $129.84 | -1.72% | — | — | — | — | −42,850 | EXITED |
| 42 | CNMD | CONMED CORP | $35.16 | 0.09% | — | — | — | — | −104,129 | EXITED |
Source: SEC EDGAR · accession 0002088557-26-000005. 13F discloses long positions only — shorts, foreign equities, and options are excluded.